The case remains open for further proceedings, so we'll see what becomes public as those cases are rolled out.
Over the last couple of weeks, though, I have found discussion of Bad Actors, FINRA and the proposed reverse split, and the OTC's reasons for discontinuing quotation of SpongeTech, all to be very interesting. Very.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.